PIRTOLI, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 10.316
EU - Europa 8.547
AS - Asia 4.580
SA - Sud America 745
Continente sconosciuto - Info sul continente non disponibili 282
AF - Africa 230
OC - Oceania 24
Totale 24.724
Nazione #
US - Stati Uniti d'America 10.133
GB - Regno Unito 2.058
CN - Cina 1.602
RU - Federazione Russa 1.601
SG - Singapore 1.389
IT - Italia 1.152
IE - Irlanda 1.029
UA - Ucraina 643
BR - Brasile 623
SE - Svezia 560
DE - Germania 494
VN - Vietnam 433
FR - Francia 425
HK - Hong Kong 375
FI - Finlandia 247
KR - Corea 207
IN - India 149
ZA - Sudafrica 122
ES - Italia 101
CA - Canada 96
TR - Turchia 77
BD - Bangladesh 64
NL - Olanda 47
MX - Messico 46
JP - Giappone 43
IQ - Iraq 42
PL - Polonia 36
NG - Nigeria 33
AR - Argentina 31
BE - Belgio 30
ID - Indonesia 26
AU - Australia 23
PK - Pakistan 23
SA - Arabia Saudita 22
CO - Colombia 20
IR - Iran 20
UZ - Uzbekistan 20
AT - Austria 19
EC - Ecuador 19
LT - Lituania 18
MY - Malesia 16
VE - Venezuela 16
IM - Isola di Man 14
KE - Kenya 14
MA - Marocco 13
DK - Danimarca 11
TN - Tunisia 11
CL - Cile 10
PH - Filippine 10
NP - Nepal 9
CI - Costa d'Avorio 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
JM - Giamaica 8
UY - Uruguay 8
CR - Costa Rica 7
ET - Etiopia 7
EU - Europa 7
PE - Perù 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
EG - Egitto 6
JO - Giordania 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
GR - Grecia 5
HU - Ungheria 5
RS - Serbia 5
KZ - Kazakistan 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
PS - Palestinian Territory 3
BH - Bahrain 2
BW - Botswana 2
CY - Cipro 2
GA - Gabon 2
LK - Sri Lanka 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 24.431
Città #
Southend 1.774
Dublin 1.007
Dallas 965
Singapore 850
Fairfield 841
Ashburn 760
Chandler 617
San Jose 529
Santa Clara 528
Jacksonville 491
Moscow 441
Woodbridge 404
Beijing 402
Wilmington 373
Hong Kong 360
Milan 318
Seattle 308
Houston 306
Ann Arbor 300
Hefei 265
Cambridge 250
Council Bluffs 228
Seoul 203
New York 202
Princeton 197
Siena 194
Nanjing 173
The Dalles 152
Menlo Park 144
Ho Chi Minh City 132
Los Angeles 125
Helsinki 122
Rome 119
Johannesburg 112
Fremont 109
Lauterbourg 97
San Mateo 94
Hanoi 93
Munich 86
Dearborn 76
Málaga 70
Boardman 68
Buffalo 57
Shanghai 55
Florence 52
Shenyang 51
São Paulo 49
Columbus 47
Izmir 47
Nanchang 47
San Diego 45
London 42
Orem 41
Dong Ket 37
Tianjin 37
Abuja 31
Kunming 30
Brussels 29
Montreal 29
Toronto 29
Warsaw 29
Atlanta 28
Lancaster 28
Phoenix 28
Tokyo 27
Rio de Janeiro 26
Turku 25
Hebei 24
Changsha 23
Jinan 23
Redondo Beach 23
Chennai 22
Denver 22
San Francisco 22
Zhengzhou 22
Bengaluru 21
Brooklyn 20
Chicago 20
Da Nang 20
Falkenstein 19
Haiphong 19
Frankfurt am Main 18
Guangzhou 18
Jiaxing 18
Nuremberg 18
Amsterdam 17
Boston 17
Mumbai 17
Venezia 17
Hangzhou 16
Redwood City 16
Stockholm 16
Tashkent 16
Naples 15
Turin 15
Bari 14
Bologna 14
Douglas 14
Belo Horizonte 13
Düsseldorf 13
Totale 16.433
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 413
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 379
Adjuvant radiotherapy after radical prostatectomy: multinstitutional experience 350
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 349
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 342
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma 338
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 334
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 326
microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to Temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells 316
Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence 313
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 307
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 307
Diffusion-weighted magnetic resonance diagnosis of local recurrences of prostate cancer after radical prostatectomy: preliminary evaluation on twenty-seven cases 296
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 296
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 296
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 286
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 278
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 277
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 277
Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells 276
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 267
Beta-catenin and Gli1 are prognostic markers in glioblastoma 264
Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma 259
Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells 258
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and Temozolomide combined treatments 250
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 242
AUTOCOUNTER, an ImageJ JavaScript to analyze LC3B-GFP expression dynamics in autophagy-induced astrocytoma cells 241
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 241
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). 240
Associazione Epirubicina e Vincristina (Ev) nel trattamento del carcinoma mammario metastatico. Risultati preliminari 238
Lymphoepithelioma-like carcinoma of the endometrium 236
Autofagia nei gliomi HG: analisi ed interpretazione di dati clinici e biologici 235
Beta-Catenin and Gli-1 as prognostic markers in Glioblastoma Multiforme. 233
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 225
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 224
Diffusion-weighted MR volumetry for assessing the response of rectal cancer to combined radiation therapy with chemotherapy 223
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status 222
Emerging roles of microRNA in modulating cell-death processes in malignant glioma 222
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 222
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 219
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 218
MR Volumetry of Rectal Cancer: DWI versus T2-weighted data sets. 217
Restaging patients with N2 non-small cell lung cancer after neoadjuvant therapy: TCMS accuracy using a multi-criteria approach 217
Carcinoma with eccrine differentiation arising in a seborrhoeic keratosis. 217
Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines 216
Chirurgia conservativa e radioterapia a dosi "moderate" nel carcinoma mammario in fase iniziale 216
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 215
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 213
The prognostic role of Beclin 1 protein expression in high-grade gliomas 205
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes 205
Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective? 201
Surrenalectomia medica con aminoglutetimide nel carcinoma mammario in fase avanzata 198
In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, Mib1, and topoisomerase IIα protein expression. 194
Spindle cell lipoma of the orbit: a case report of an unusual orbital pathology 194
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 194
Beta-catenin and Gli1 are important prognostic factors in glioblastoma: combination with p53, EGFR and Mib1 markers to predict long term survival (paper #1628) 193
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology) 192
Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report [La volumetria con risonanza magnetica pesata in diffusione nella valutazione della risposta alla chemio-radioterapia nel tumore del retto: studio preliminare] 192
Three-dimensional conformal radiotherapy, temozolomide chemotherapy and high-dose fractionated stereotactic boost in a protocol driven, post-operative treatment schedule for high-grade gliomas. 191
Impact of timing of radiotherapy after conservative breast surgery on local control and metastases in pTis-T1-T2 N0 patients.Tuscany and Umbria Radiotherapy Departments experience. 189
Basi scientifiche per la definizione di linee-guida in ambito clinico per i tumori della tiroide dell’epitelio follicolare. 189
Benign lymphoepithelial lesion associated with squamous cell carcinoma of the skin: an immunohistochemical and molecular genetic study 187
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO). 184
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 179
Neoplasie di encefalo, occhio-orbita, ipofisi e midollo spinale 178
Neoplasie della sfera Otorinolaringoiatrica 176
High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer 173
Risultati terapeutici nel carcinoma mammario sottoposto a trattamento conservative basato sulla radioterapia. Lo standard di cura nel sud-est della Toscana negli anni 1996-2000 171
Tumori tiroidei 170
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: a role for autophagy 170
Primary neuroendocrine (Merkel cell) carcinoma of the eyelid in a young woman - Report of a Case 169
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism? 168
Lymphatic vascularization in prostate adenocarcinoma: Correlation with tumor grade, androgen withdrawal and prognosis 164
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 164
NEOPLASIE CEREBRALI, LINEE GUIDA AIOM. 163
The role of Radiation Oncologist in the management of antineoplastic drugs in Italy 162
Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects 161
Cytoplasmatic expression of the Beclin 1 autophagy protein gene product in a sereis of malignant glioma patients undergoing radio- and chemotherapy: a preliminary report. 160
Autophagy in Human Brain Cancer 160
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 158
Unresectable retroperitoneal malignant fibrous histiocytoma: Prolonged complete remission following chemoradiotherapy 157
Epidermal Growth Factor Receptor Expression May Correlate with Survival Through Clinical and Radiological Features of Aggressiveness in Glioblastoma Treated with Radiochemotherapy 156
Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas 154
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 147
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 147
La radioterapia oncologica 146
In Regard to Kubicek et al. 146
Oncology and a time of crisis. Science, complexity, ethic values, and incertitude. An argumentative essay 143
The Istituto Toscano Tumori (ITT) and the radiotherapy Centers. 141
Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques [La radioterapia dei gliomi maligni. I risultati delle modalità tradizionali di trattamento e le prospettive delle tecniche avanzate] 141
Updating the role of radiotherapy in the management of epithelial ovarian cancer 141
Polichemioterapia precauzionale con cmf classico nel carcinoma della mammella con linfonodi ascellari positivi 141
Restaging brain computerized tomography after treatment of non-operable lung neoplasms [La Tomografia Computerizzata dell'encefalo nella ristadiazione dopo terapia delle neoplasie polmonari non suscettibili di trattamento chirurgico] 140
null 139
Prophylactic whole brain irradiation after complete response to primary treatment in limited stage small cell lung cancer: the experience of four radiotherapy units in Tuscany. 138
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 136
Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. 135
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in twelve italian radiation oncology centers 135
Conservative surgery and radiotherapy for ductal carcinoma of the breast. A retrospective analysis of 141 patients 133
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 130
Totale 21.446
Categoria #
all - tutte 70.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.106 0 0 132 97 69 54 58 73 70 141 118 294
2022/20232.066 114 162 291 292 200 401 34 177 197 86 65 47
2023/20241.679 59 38 139 85 61 451 622 59 9 52 22 82
2024/20253.043 92 146 290 164 396 210 48 180 180 128 362 847
2025/20267.870 631 1.049 757 915 1.694 318 834 208 258 490 151 565
2026/2027889 270 366 253 0 0 0 0 0 0 0 0 0
Totale 24.724